JPS6355492B2 - - Google Patents

Info

Publication number
JPS6355492B2
JPS6355492B2 JP61001227A JP122786A JPS6355492B2 JP S6355492 B2 JPS6355492 B2 JP S6355492B2 JP 61001227 A JP61001227 A JP 61001227A JP 122786 A JP122786 A JP 122786A JP S6355492 B2 JPS6355492 B2 JP S6355492B2
Authority
JP
Japan
Prior art keywords
heparin
solution
oxalate
salt
calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
JP61001227A
Other languages
English (en)
Japanese (ja)
Other versions
JPS61197521A (ja
Inventor
Gurai Jan
Shoai Jan
Pieeru Deyukuro Jan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Choay SA
Original Assignee
Choay SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Choay SA filed Critical Choay SA
Publication of JPS61197521A publication Critical patent/JPS61197521A/ja
Publication of JPS6355492B2 publication Critical patent/JPS6355492B2/ja
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
JP61001227A 1977-08-08 1986-01-07 ヘパリン製剤 Granted JPS61197521A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB33170/77A GB1602439A (en) 1977-08-08 1977-08-08 Purified heparin
GB33170/77 1977-08-08
GB52047/77 1977-12-14

Publications (2)

Publication Number Publication Date
JPS61197521A JPS61197521A (ja) 1986-09-01
JPS6355492B2 true JPS6355492B2 (fr) 1988-11-02

Family

ID=10349469

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61001227A Granted JPS61197521A (ja) 1977-08-08 1986-01-07 ヘパリン製剤

Country Status (3)

Country Link
JP (1) JPS61197521A (fr)
BE (1) BE869609A (fr)
GB (1) GB1602439A (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0227797A (ja) * 1988-07-15 1990-01-30 Matsushita Electric Ind Co Ltd シールドケース

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3144325T3 (da) * 2010-09-14 2021-01-25 Univ Miyazaki Heparin med høj renhed og fremstillingsfremgangsmåde dertil

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0227797A (ja) * 1988-07-15 1990-01-30 Matsushita Electric Ind Co Ltd シールドケース

Also Published As

Publication number Publication date
BE869609A (fr) 1979-02-08
GB1602439A (en) 1981-11-11
JPS61197521A (ja) 1986-09-01

Similar Documents

Publication Publication Date Title
US4340589A (en) Antithrombin preparation and process for the production thereof
DE3885374T2 (de) Stabile wässerige Thrombinlösung.
US3868358A (en) Protamine-insulin product
JPS6129327B2 (fr)
HU211465A9 (en) Novel compositions containing hyaluronic acid associates and a process for preparing the same
JPH0231081B2 (fr)
US3933996A (en) Composition comprising radioactive labeled-fibrinogen and albumin
EP1225898A2 (fr) Compositions pharmaceutiques contenant un medicament antibiotique de fluoroquinolone et une gomme xanthan
US5028587A (en) Mixed crystals of insulin and insulin derivatives
US4168377A (en) Process of preparing mixed heparin salts
KR101847846B1 (ko) 고순도 헤파린 및 그 제조방법
JPH03243601A (ja) 血液凝固の制御能をもつムコ多糖組成物およびその製造方法
EP0123375B1 (fr) Préparation de gamma-globuline à titre d'administration intraveineuse
CN105324398B (zh) 用于生产化学修饰的肝素的新方法
US4185093A (en) Preparation and method for treatment of hypocalcemia, hypophosphatemia and downer cow syndrome in animals
DE2459915B2 (de) Aktive Verbindung des Plasminogen-Typs, Verfahren zu ihrer Reinigung und ihre Verwendung
DE1442134C3 (de) In vivo antikoagulierend wirkendes und defibrinierendes Enzym
EP0421508B1 (fr) Glycosaminoglycuronane sulphoné à activité antithrombotique
JPS61197521A (ja) ヘパリン製剤
EP0127025B1 (fr) Procédé de préparation d'un concentré du facteur anti-hémophilique
GB2027728A (en) Physiologically Acceptable Heparin
US1000214A (en) Process of preparing extractive compounds of the suprarenal gland.
DE2409650C3 (de) Verwendung wäßriger Lösung von menschlichem Serum-Haptoglobin bei der Bekämpfung von hämolytischen Nierenstörungen
JPS5823631A (ja) 安定な固体の人血漿コリンエステラ−ゼ製剤の製法
JP2946015B2 (ja) 安定な抗ウィルス点滴用注射剤